Company: RGBP
Filing Date: 2025-02-24
Form Type: 253G1
Source: 0001493152-25-008067
Chunk: 84

Company: Regen BioPharma Inc
Filing Date: 2025-02-24
Form: 253G1
Chunk 84
---
 | (1,239,646 | ) |
| Portion of Enterprise Value Attributable to Shareholders |     | $ |    708,916 |   |
| Fair Value per Shares                                    |     | $ |     0.0155 |   |

The abovementioned constitute the Company’s sole related party investment securities as of September 30, 2024.

As of September 30, 2024:

470,588 Common Shares of Zander Therapeutics, Inc.

| Basis |       |     | Fair Value |       |     | Total             
 Unrealized  Gains |     |     | Net                
 Unrealized Gain or 
 (Loss)             
 realized during    
 the                
 quarter ended      
 September          
 30, 2024           |    |   |
|:------|------:|:----|:-----------|------:|:----|:------------------|----:|:----|:-------------------|:---|:--|
| $     | 5,741 |     | $          | 6,496 |     | $                 | 755 |     | $                  | (0 | ) |

725,000 Series M Preferred of Zander Therapeutics, Inc.

| Basis |        |     | Fair Value |        |     | Total      
 Unrealized 
 Loss       |        |   |     | Net                
 Unrealized Gain or 
 (Loss)             
 realized during    
 the                
 quarter ended      
 September          
 30, 2024           |    |   |
|:------|-------:|:----|:-----------|-------:|:----|:-----------|:-------|:--|:----|:-------------------|:---|:--|
| $     | 13,124 |     | $          | 11,238 |     | $          | (1,866 | ) |     | $                  | (0 | ) |

| 62 |

NOTE 9. STOCK TRANSACTIONS

On October 13 2023 the Company issued 16,710 common shares for cash consideration of $22,726.

On October 27 2023 the Company issued 35,785 common shares for cash consideration of $46,091.

On November 10, 2023 the Company issued 31,732 common shares for cash consideration of $38,205.

On November 27, 2023 the Company issued 33,989 common shares for cash consideration of $32,629.

On December 11